Status:

UNKNOWN

Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection

Lead Sponsor:

Inmunotek S.L.

Collaborating Sponsors:

BioClever 2005 S.L.

Conditions:

COVID-19

Eligibility:

All Genders

18-70 years

Phase:

PHASE3

Brief Summary

The purpose of the study is to confirm if BACTEK-R (MV130) provides clinical benefit in subject with mild pneumonia (CURB-65≤2) by COVID-19 admitted to the Hospital.

Detailed Description

This is a prospective, open-label, randomized pilot study to evaluate the efficacy and safety of BACTEK-R (MV130) in subject with mild pneumonia due to COVID-19 infection.

Eligibility Criteria

Inclusion

  • \- Subjects who voluntarily sign informed consent forms
  • \- Both genders.
  • \- Subjects aged between 18 and 70 years.
  • -Subjects capable of complying with the treatment
  • \- Subjects admitted to hospital with non-severe pneumonia (CURB-65≤2) by COVID-19
  • \- Confirmatory test for COVID-19 infection

Exclusion

  • \- Subjects who has not signed informed consent forms
  • \- Subjects included in another clinical trial.
  • \- Subjects under treatment with immunosuppressants.
  • \- Subjects in treatment with another type of immunotherapy.
  • \- Subjects who are or have been undergoing treatment with metformin.
  • \- Subjects who are or have been treated with statins.
  • \- Subjects who are or have been under treatment with sertraline.
  • \- Pregnant women.
  • \- Subjects who cannot offer cooperation and / or have serious psychiatric disorders.
  • -Subjects who are allergic to any of the components of BACTEK-R (MV130).
  • \- Subjects with pathologies described in the Charlson index

Key Trial Info

Start Date :

June 10 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 31 2022

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04363814

Start Date

June 10 2020

End Date

January 31 2022

Last Update

November 11 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Metropolitano Santiago

Santiago de los Caballeros, Dominican Republic, 51000